PDCD1 and neoplasm: They are considered to have high genomic instability and immunogenic phenotypes, harboring more tumor-specific neoantigens and increased amounts of tumor-infiltrating lymphocytes (TILs), resulting in upregulation of compensatory immune checkpoint mechanisms and the overexpression of PD-1 and PD-L1[36,37].